Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases

Current Biology

Volumn 15, Issue 7, 2005, Pages 661-666

  Dutko, James A ^a   Schäfer, Alexandra ^b   Kenny, Alison E ^a   Cullen, Bryan R ^b   Curcio, M Joan ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; SACCHAROMYCES CEREVISIAE;

EID: 17144384021     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2005.02.051     Document Type: Article

References (37)

1. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650
2. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
3. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
4. R.S. Harris, K.N. Bishop, A.M. Sheehy, H.M. Craig, S.K. Petersen-Mahrt, I.N. Watt, M.S. Neuberger, and M.H. Malim DNA deamination mediates innate immunity to retroviral infection Cell 113 2003 803 809
5. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 2003 21 31
6. H.L. Wiegand, B.P. Doehle, H.P. Bogerd, and B.R. Cullen A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins EMBO J. 23 2004 2451 2458
7. K.N. Bishop, R.K. Holmes, A.M. Sheehy, N.O. Davidson, S.J. Cho, and M.H. Malim Cytidine deamination of retroviral DNA by diverse APOBEC proteins Curr. Biol. 14 2004 1392 1396
8. Y.H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B.M. Peterlin Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication J. Virol. 78 2004 6073 6076
9. F.J. Kim, J.L. Battini, N. Manel, and M. Sitbon Emergence of vertebrate retroviruses and envelope capture Virology 318 2004 183 191
10. M. Aye, B. Irwin, N. Beliakova-Bethell, E. Chen, J. Garrus, and S. Sandmeyer Host factors that affect Ty3 retrotransposition in Saccharomyces cerevisiae Genetics 168 2004 1159 1176
11. E.C. Bolton, A.S. Mildvan, and J.D. Boeke Inhibition of reverse transcription in vivo by elevated manganese ion concentration Mol. Cell 9 2002 879 889
12. D.T. Scholes, M. Banerjee, B. Bowen, and M.J. Curcio Multiple regulators of Ty1 transposition in Saccharomyces cerevisiae have conserved roles in genome maintenance Genetics 159 2001 1449 1465
13. A. Jarmuz, A. Chester, J. Bayliss, J. Gisbourne, I. Dunham, J. Scott, and N. Navaratnam An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 Genomics 79 2002 285 296
14. S.G. Conticello, C.J. Thomas, S.K. Petersen-Mahrt, and M.S. Neuberger Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases Mol. Biol. Evol. 22 2005 367 377
15. Q. Yu, D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N.R. Landau APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication J. Biol. Chem. 279 2004 53379 53386
16. P. Turelli, B. Mangeat, S. Jost, S. Vianin, and D. Trono Inhibition of hepatitis B virus replication by APOBEC3G Science 303 2004 1829
17. P. Turelli, S. Vianin, and D. Trono The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay J. Biol. Chem. 279 2004 43371 43373
18. T.H. Eickbush, and H.S. Malik Origins and evolution of retrotransposons DNA Mobile II N. Craig R. Craigie M. Gellert A. Lambowitz 2002 American Society for Microbiology Washington, D.C. 1111 1144
19. M.J. Curcio, and D.J. Garfinkel Single-step selection for Ty1 element retrotransposition Proc. Natl. Acad. Sci. USA 88 1991 936 940
20. E.N. Newman, R.K. Holmes, H.M. Craig, K.C. Klein, J.R. Lingappa, M.H. Malim, and A.M. Sheehy Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity Curr. Biol. 15 2005 166 170
21. J.M. Kim, S. Vanguri, J.D. Boeke, A. Gabriel, and D.F. Voytas Transposable elements and genome organization: a comprehensive survey of retrotransposons revealed by the complete Saccharomyces cerevisiae genome sequence Genome Res. 8 1998 464 478
22. I.K. Jordan, and J.F. McDonald Tempo and mode of Ty element evolution in Saccharomyces cerevisiae Genetics 151 1999 1341 1351
23. M.J. Curcio, A.M. Hedge, J.D. Boeke, and D.J. Garfinkel Ty RNA levels determine the spectrum of retrotransposition events that activate gene expression in Saccharomyces cerevisiae Mol. Gen. Genet. 220 1990 213 221
24. A. Schafer, H.P. Bogerd, and B.R. Cullen Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor Virology 328 2004 163 168
25. V. Zennou, D. Perez-Caballero, H. Gottlinger, and P.D. Bieniasz APOBEC3G incorporation into human immunodeficiency virus type 1 particles J. Virol. 78 2004 12058 12061
26. T.M. Alce, and W. Popik APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein J. Biol. Chem. 279 2004 34083 34086
27. S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman The interaction between HIV-1 Gag and APOBEC3G J. Biol. Chem. 279 2004 33177 33184
28. G.A. Coburn, H.L. Wiegand, Y. Kang, D.N. Ho, M.M. Georgiadis, and B.R. Cullen Using viral species specificity to define a critical protein/RNA interaction surface Genes Dev. 15 2001 1194 1205
29. D. Conte, E. Barber, M. Banerjee, D.J. Garfinkel, and M.J. Curcio Posttranslational regulation of Ty1 retrotransposition by mitogen-activated protein kinase Fus3 Mol. Cell. Biol. 18 1998 2502 2513
30. Q. Yu, R. Konig, S. Pillai, K. Chiles, M. Kearney, S. Palmer, D. Richman, J.M. Coffin, and N.R. Landau Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome Nat. Struct. Mol. Biol. 11 2004 435 442
31. N. Bachman, Y. Eby, and J.D. Boeke Local definition of Ty1 target preference by long terminal repeats and clustered tRNA genes Genome Res. 14 2004 1232 1247
32. M. Marin, K.M. Rose, S.L. Kozak, and D. Kabat HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation Nat. Med. 9 2003 1398 1403
33. X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.F. Yu Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 302 2003 1056 1060
34. A. Mehle, B. Strack, P. Ancuta, C. Zhang, M. McPike, and D. Gabuzda Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway J. Biol. Chem. 279 2004 7792 7798
35. M. Butler, T. Goodwin, M. Simpson, M. Singh, and R. Poulter Vertebrate LTR retrotransposons of the Tf1/sushi group J. Mol. Evol. 52 2001 260 274
36. E.M. McCarthy, and J.F. McDonald Long terminal repeat retrotransposons of Mus musculus Genome Biol. 5 2004 R14
37. C. Esnault, O. Heidmann, F. Delebecque, M. Dewannieux, D. Ribet, A.J. Hance, T. Heidmann, and O. Schwartz APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses Nature 433 2005 430 433